Understanding Certificates of Analysis (COAs) for Research Peptides

What is a Certificate of Analysis?

A Certificate of Analysis (COA) is a formal document issued by an analytical testing laboratory confirming the identity, purity, and quality characteristics of a specific batch of a research compound. For research peptides, the COA is the single most important quality document available — it converts supplier claims into verifiable, traceable data. Without a batch-specific COA, a purity or quality claim has no more evidential weight than marketing copy.

Understanding how to read and critically evaluate a peptide COA is a fundamental research skill. Not all COAs are equivalent in the information they provide, the rigour of the testing methods used, or the independence of the testing laboratory. This guide covers every section of a research-grade peptide COA, what each test measures, what results to expect, and the red flags that should prompt further investigation.

Why the COA Matters for Research Validity

Research results are only as reliable as the compounds used to generate them. A peptide with 90% purity contains 10% uncharacterised impurities — peptide fragments, synthesis byproducts, residual reagents, or incorrect sequences — that can produce their own biological effects, confound dose-response relationships, and make results non-reproducible across different batches or suppliers.

For cell culture experiments, additional contamination concerns apply: endotoxins (lipopolysaccharides from bacterial cell walls) trigger strong inflammatory responses in cell lines at very low concentrations, and this response can completely mask or overwhelm the specific signal being studied. A COA that doesn't address endotoxin contamination is incomplete for any in vitro application.

Section 1: HPLC Purity Analysis

High-Performance Liquid Chromatography (HPLC) is the primary method used to measure the purity of a research peptide. HPLC works by passing the dissolved sample through a column packed with a stationary phase, where different molecular species travel at different speeds based on their chemical interactions with the column material. The separated compounds are detected as they elute from the column, typically using UV absorbance at 214–220 nm (which detects the peptide bond common to all amino acids).

Reading an HPLC Chromatogram

The HPLC result is reported as a chromatogram — a graph showing detector response (y-axis, proportional to compound concentration) versus time (x-axis, representing elution order). Each peak represents a distinct molecular species in the sample. The target peptide should appear as the dominant, tallest peak. Smaller peaks represent impurities.

Purity percentage is calculated as the area of the target peak divided by the total area of all peaks, expressed as a percentage. A result of 99.1% purity means 99.1% of the detected material is the target compound and 0.9% is other species. For research-grade peptides, the benchmark is:

• ≥98% purity: Standard minimum for research use
• ≥99% purity: Premium research grade, appropriate for sensitive assays
• ≥95% purity: Acceptable for some general purposes but not recommended for quantitative mechanistic research

Purity below 95% should prompt careful consideration: is the impurity profile known? Are the impurities biologically active? Would the impurity load materially affect the research question?

Reversed-Phase vs Ion-Exchange HPLC

Most peptide COAs use reversed-phase HPLC (RP-HPLC) with a C18 column, which is the industry standard for peptide purity analysis. Some suppliers may use ion-exchange chromatography, which separates by charge rather than hydrophobicity. RP-HPLC is generally preferred for peptides because it provides better separation of closely related species and is the established method against which industry standards are set.

Section 2: Mass Spectrometry Identity Confirmation

HPLC purity analysis tells you what fraction of the sample is the major component — but it does not tell you whether that major component is actually the peptide it's supposed to be. A sample could theoretically show 99% purity on HPLC while the "pure" compound is actually a different peptide with similar chromatographic properties. Mass spectrometry (MS) closes this gap by providing molecular identity confirmation.

How Mass Spectrometry Works for Peptides

Mass spectrometry measures the mass-to-charge ratio (m/z) of ionised molecules. For peptides, electrospray ionisation (ESI) is the most commonly used ionisation method, as it gently ionises large molecules without fragmenting them, producing intact molecular ions in multiple charge states. The mass spectrometer measures the m/z values of these ions, and the software reconstructs the molecular mass from the observed charge state distribution.

The identity confirmation step compares the observed (measured) molecular mass to the theoretical molecular mass of the target peptide, calculated from its amino acid sequence. For example, BPC-157 has a theoretical mass of approximately 1,419 Da. A mass spectrometry result showing an observed mass of 1,419.2 Da confirms identity within acceptable analytical tolerance (±1 Da is the typical standard).

What MS Identity Confirmation Catches

Mass spectrometry can detect: incorrect amino acid sequences (wrong peptide); truncated sequences (synthesis incomplete, missing amino acids); oxidised or otherwise chemically modified residues; and gross misidentification (completely different compound). It cannot reliably distinguish stereoisomers (D- vs L-amino acid configurations) or detect all post-translational modifications without additional techniques — these require more specialised testing.

Section 3: Endotoxin Testing

Endotoxins are lipopolysaccharide (LPS) molecules derived from the outer membrane of gram-negative bacteria. They are extraordinarily potent activators of innate immune responses, triggering inflammatory cascades at concentrations in the picogram-per-millilitre range in sensitive assays. For research peptides, endotoxin contamination can arise during the synthesis process (bacterial contamination of reagents or equipment), lyophilisation, or handling.

The LAL Test

The standard method for endotoxin detection is the Limulus Amebocyte Lysate (LAL) test, which uses a reagent derived from horseshoe crab blood that clots specifically in the presence of endotoxin. More modern alternatives include recombinant Factor C (rFC) assays, which provide equivalent sensitivity without the use of horseshoe crab biological material.

For research-grade peptides, the endotoxin specification is typically <5 Endotoxin Units per milligram (EU/mg). This threshold is designed to ensure that the endotoxin contribution from the peptide does not confound in vitro assay results in typical research concentrations.

Section 4: Batch Traceability

Every COA should include a unique batch or lot number that corresponds exactly to the labeling on the peptide vial. This batch number is the link between the specific vial you are using and the quality testing results that apply to it. Without a matching batch number, there is no way to confirm that the tested material is the same as the supplied material.

Reputable suppliers maintain records that allow any vial to be traced to its production batch, testing results, and storage history. Batch traceability is a basic requirement of good laboratory practice (GLP) and becomes particularly important when sharing research results or troubleshooting unexpected findings.

Section 5: Additional Testing Parameters

Peptide Content / Net Peptide Content

Some COAs report a net peptide content value alongside HPLC purity. This is an important distinction: HPLC purity reflects the fraction of the material that is the target compound, but the raw weight of a lyophilised peptide powder can include water (moisture content) and counter-ions (salts used in the synthesis and purification process, typically trifluoroacetate or acetate). Net peptide content corrects for these non-peptide components and gives a more accurate picture of how much active compound is actually present per milligram of powder.

Optical Purity / Chiral Purity

Amino acids exist as L- (naturally occurring) and D-enantiomers. Solid-phase peptide synthesis uses L-amino acids by convention, but racemisation (conversion of L to D at specific positions) can occur during synthesis, particularly at the C-terminal residue or in sequences containing difficult amino acids. Some COAs include chiral purity testing to confirm that the amino acid configuration is correct throughout the sequence.

Red Flags: What to Watch For

• No COA available or "available upon request": A quality supplier makes COAs accessible before purchase. "Available upon request" means the COA may not be batch-specific or may not exist.
• In-house testing only: Supplier-conducted testing is a significant conflict of interest. Third-party laboratory testing provides independent verification.
• No batch number on the COA: Without a lot number that matches the vial, the COA cannot be confirmed to apply to the material supplied.
• Purity below 95%: Sub-95% purity should prompt explanation — is the impurity profile known and acceptable for the intended research use?
• Missing mass spectrometry: HPLC purity without MS identity confirmation leaves the most important question — is this actually the right compound? — unanswered.
• Generic or reused COAs: A COA that appears the same across different batches, or that has no production date, is likely not batch-specific.
• Implausible purity claims: Claims of 100% purity should be treated with scepticism — analytical methods always have detection limits, and claiming exactly 100% typically indicates the supplier doesn't understand what the number means.

Third-Party vs In-House Testing

Third-party testing means the compound was sent to an independent analytical laboratory — one with no financial stake in the results — for testing. The laboratory applies standardised methods, maintains calibration and quality control records, and issues a report under their own quality system. This independence is what gives third-party testing its evidentiary value.

In-house testing means the supplier tested the compound themselves, using their own equipment and staff. This is not inherently invalid — large manufacturers with ISO-certified quality systems do rigorous in-house testing — but for research peptide suppliers, in-house testing without third-party verification provides much weaker quality assurance, as there is no independent check on the methods, equipment calibration, or results.

Frequently Asked Questions

What is the difference between HPLC purity and net peptide content?

HPLC purity reflects what fraction of the detectable material in the sample is the target compound. Net peptide content corrects for the non-peptide material in the lyophilised powder — primarily water (moisture) and counter-ions (salts). A peptide powder could show 99% HPLC purity but only 70% net peptide content if it contains significant moisture and salt content. Net peptide content is the more accurate measure of actual active compound per milligram of powder.

Why can't I trust purity alone without mass spectrometry?

HPLC purity tells you the fraction of the sample that is the major component. It doesn't tell you whether that major component is actually the peptide it's supposed to be. A sample could be 99% pure by HPLC, but that 99% could be the wrong peptide, a truncated sequence, or a modified compound. Mass spectrometry identity confirmation is the test that answers "is this actually BPC-157 (or Semaglutide, or TB-500)?" independently of purity.

What does EU/mg mean in endotoxin testing?

EU stands for Endotoxin Units, the standardised measure of endotoxin activity used in the LAL test. EU/mg means endotoxin units per milligram of compound tested. The research-grade standard for research peptides is <5 EU/mg, meaning less than 5 endotoxin units of activity per milligram of peptide. This threshold is designed to keep endotoxin contributions below the level that would trigger significant inflammatory responses in standard in vitro assay conditions.

How do I verify that the COA applies to the specific vial I received?

Compare the batch or lot number on the product label with the batch/lot number on the COA. They should match exactly. If you receive a product without a batch number on the label, or a COA without a lot number, the traceability chain is broken and you cannot confirm the COA applies to your specific material.

Is reversed-phase HPLC the only valid method for purity testing?

No, but it is the most widely used and best-established method for peptide purity analysis. Other methods including ion-exchange HPLC, size-exclusion HPLC, and capillary electrophoresis can provide complementary information. A COA using a non-standard method should ideally include details of the method parameters so the results can be interpreted correctly.

What should I do if I receive a compound that doesn't match its COA?

Document the discrepancy thoroughly — photograph the vial label and COA together, note the batch numbers, and record exactly what doesn't match. Contact the supplier with this documentation and request an explanation or replacement. Reputable suppliers take COA discrepancies seriously and should be able to provide clarification within a short timeframe. If a supplier is unresponsive to legitimate COA concerns, this is a significant quality signal.